{"id":11439,"date":"2022-07-01T20:37:35","date_gmt":"2022-07-02T00:37:35","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/31st-annual-cancer-progress-conference\/"},"modified":"2022-07-14T15:06:25","modified_gmt":"2022-07-14T19:06:25","slug":"cancer-progress-2020","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/cancer-progress-2020","title":{"rendered":"31st Annual Cancer Progress Conference"},"content":{"rendered":"

Vanessa Lucey, PhD, MBA<\/a>, director of CRI Clinical Accelerator and Venture Fund, speaks on the "Investing into Oncology: Who, What and Where?" (May 5, 1:30–2:45 pm) panel and “Oncology Modalities Facing Off: Room for Many or One to Rule them All?” panel (May 6, 5:45–7:00 pm). <\/strong><\/p>\n

UPDATE: Cancer Progress is going virtual for its 31st Annual Conference.<\/p>\n

In light of the ongoing and still evolving novel coronavirus (COVID-19) outbreak, and with the recent announcement by the CDC<\/a> on the restrictions on gatherings over 50 people, the Cello Health Cancer Progress Committee has made the difficult decision to convert this event to a two-day series of webinars on the original dates in place of the face-to-face event at Convene in New York City. Updates and information will be made as soon as possible.<\/p>\n

\n

\nSince 1989, Cancer Progress invites a discussion of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives in two days of interactive dialogue. This conference offers pivotal topics, frank discussions, vigorous debate, lively audience participation, and generous networking throughout the meeting during breaks, luncheons, reception, and dinner.<\/p>\n

The 31st Annual Meeting on May 5-6, 2020, provides a quality learning experience with experienced speakers, breadth and depth of coverage, and value of professional contacts. <\/p>\n

Cancer Progress is organized by Cello Health BioConsulting.<\/p>\n

Register at cancerprogressbycellohealth.com<\/a>.<\/p>\n

Photos courtesy of Cello Health BioConsulting<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

CRI's Vanessa Lucey, PhD, MBA, speaks on the "Investing into Oncology" and "Oncology Modalities Facing Off" panels.<\/p>\n","protected":false},"featured_media":4647,"template":"","events_categories":[203],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11439","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-cri-speaks"],"acf":[],"yoast_head":"\n31st Annual Cancer Progress Conference<\/title>\n<meta name=\"description\" content=\"CRI's Vanessa Lucey, PhD, MBA, speaks on the "Investing into Oncology" and "Oncology Modalities Facing Off" panels.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"31st Annual Cancer Progress Conference\" \/>\n<meta property=\"og:description\" content=\"CRI's Vanessa Lucey, PhD, MBA, speaks on the "Investing into Oncology" and "Oncology Modalities Facing Off" panels.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T19:06:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/d1594516-b042-407e-9dcb-5e3f4ba767aa.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"31st Annual Cancer Progress Conference\" \/>\n<meta name=\"twitter:description\" content=\"CRI's Vanessa Lucey, PhD, MBA, speaks on the "Investing into Oncology" and "Oncology Modalities Facing Off" panels.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/d1594516-b042-407e-9dcb-5e3f4ba767aa.png\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020\",\"name\":\"31st Annual Cancer Progress Conference\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ca3ff6f6-8b8f-453f-ad59-053272f016e9.png\",\"datePublished\":\"2022-07-02T00:37:35+00:00\",\"dateModified\":\"2022-07-14T19:06:25+00:00\",\"description\":\"CRI's Vanessa Lucey, PhD, MBA, speaks on the \\\"Investing into Oncology\\\" and \\\"Oncology Modalities Facing Off\\\" panels.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ca3ff6f6-8b8f-453f-ad59-053272f016e9.png\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ca3ff6f6-8b8f-453f-ad59-053272f016e9.png\",\"width\":624,\"height\":446},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"31st Annual Cancer Progress Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"31st Annual Cancer Progress Conference","description":"CRI's Vanessa Lucey, PhD, MBA, speaks on the \"Investing into Oncology\" and \"Oncology Modalities Facing Off\" panels.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020","og_locale":"es_ES","og_type":"article","og_title":"31st Annual Cancer Progress Conference","og_description":"CRI's Vanessa Lucey, PhD, MBA, speaks on the \"Investing into Oncology\" and \"Oncology Modalities Facing Off\" panels.","og_url":"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T19:06:25+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/d1594516-b042-407e-9dcb-5e3f4ba767aa.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"31st Annual Cancer Progress Conference","twitter_description":"CRI's Vanessa Lucey, PhD, MBA, speaks on the \"Investing into Oncology\" and \"Oncology Modalities Facing Off\" panels.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/d1594516-b042-407e-9dcb-5e3f4ba767aa.png","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020","url":"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020","name":"31st Annual Cancer Progress Conference","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ca3ff6f6-8b8f-453f-ad59-053272f016e9.png","datePublished":"2022-07-02T00:37:35+00:00","dateModified":"2022-07-14T19:06:25+00:00","description":"CRI's Vanessa Lucey, PhD, MBA, speaks on the \"Investing into Oncology\" and \"Oncology Modalities Facing Off\" panels.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ca3ff6f6-8b8f-453f-ad59-053272f016e9.png","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ca3ff6f6-8b8f-453f-ad59-053272f016e9.png","width":624,"height":446},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/cancer-progress-2020#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"31st Annual Cancer Progress Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11439","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/4647"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11439"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11439"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11439"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11439"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11439"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11439"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}